Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy? (Q34687431)

3 August 2017

1 reference

title

Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy? (English)

1 reference

3 August 2017

2

Jürgen Venitz

1 reference

3 August 2017

Michelle A Rudek

1

1 reference

3 August 2017

William D Figg

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

3 August 2017

1 reference

3 August 2017

22

1 reference

3 August 2017

6

1 reference

3 August 2017

705-720

1 reference

Changing views of the role of matrix metalloproteinases in metastasis

3 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Structural biochemistry and activation of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Biochemical characterization of human collagenase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Identification of MMP-18, a putative novel human matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Identification and structural and functional characterization of human enamelysin (MMP-20)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Effects of tumor necrosis factor-alpha and interferon-gamma on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Activity of type IV collagenases in benign and malignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

CNTF up-regulation of TIMP-2 in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Matrix metalloproteinase inhibitors: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Design and synthesis of piperazine-based matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Thermodynamics of chelation by tetracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Ongoing trials with matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Tetracycline derivative CMT-3 inhibits cytokine production, degranulation, and proliferation in cultured mouse and human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Inhibition of tumor cell invasiveness by chemically modified tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.9.705.34062

10.1592/PHCO.22.9.705.34062

21 January 2018

Identifiers

DOI

1 reference

release_7e572yhcwngi7lmt4yca2u2pze

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7e572yhcwngi7lmt4yca2u2pze

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference